Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.64M

combined est. value

Stock	Shares	Price	Value	Weight	As of
CRVSCorvus Pharmaceuticals, Inc.	173,130	$15.23	$2.64M	100%	2025-06-04

CRVS

Corvus Pharmaceuticals, Inc.

$2.64M

173,130 sh

All filings on record

Every Form 4 transaction we track for this filer

all 1buys 0sells 0

Stock	Transaction	Date	~6mo later
CRVSCorvus Pharmaceuticals, Inc.	Exercise $67.7K · 19,357 sh	2025-06-04	—

CRVSExercise

2025-06-04 · Corvus Pharmaceuticals, Inc.

$67.7K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.